The Effect of Nitric Oxide Inhibition on Blood Pressure Depends on Rat Strain

Forster, Jameson; Beebe, Paul; Wang, Haiying; Wood, John G.

doi:10.1006/jsre.2001.6087

Cited by 11 publications

(10 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Increased NO production decreases hypertension. The fact that Arg-treated SHHF rats in the present study did not exhibit a decrease in blood pressure may suggest that the effects of Cap on blood pressure may be through other mechanisms, that there is a strain difference in response to NO systems as noted in several previous studies (12,34,43) or that treatment was Fig. 4.…”

Section: Discussionsupporting

confidence: 48%

“…In diabetic patients with hypertension, endogenous inhibitors of NO synthase (NOS) can decrease the production of NO that acts as a vasodilator (16,39). In addition to effects on the vasculature, NO affects control of breathing directly by modulating neurotransmitter function in the carotid body and brain stem sites and/or possibly indirectly by decreasing blood pressure (10,12,22,30,32).To determine the efficacy of ACE inhibitors and Arg on diabetes and hypertension, we utilized the obese male spontaneously hypertensive heart failure (SHHF)/MccGmi-fa cp rat that develops noninsulin-dependent diabetes mellitus, obesity, hypertension, heart failure, and renal dysfunction (15,22,28,38). The "fa cp " designation reflects that the fatty (fa) gene mutation and corpulent (cp) obesity gene mutations are allelic.…”

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Effects of long-term captopril andl-arginine treatment on ventilation and blood pressure in obese male SHHF rats

Schlenker

Kost

Likness

2004

Journal of Applied Physiology

View full text Add to dashboard Cite

Schlenker, E. H., C. K. Kost, Jr., and M. M. Likness. Effects of long-term captopril and L-arginine treatment on ventilation and blood pressure in obese male SHHF rats. J Appl Physiol 97: 1032-1039, 2004. First published May 14, 2004 10.1152/japplphysiol.00255.2004We investigated the effects of captopril (Cap) and L-arginine (Arg) on hypertension and cardiopulmonary function. Our hypothesis was that Cap therapy or Arg will improve cardiopulmonary risk factors for hypertension and hypoventilation in the obese spontaneously hypertensive heart failure rat, which is characterized by hypertension, obesity, and disorders of lipid and carbohydrate metabolism. For the first study, one group of rats received Cap in drinking water, and a second group received deionized water (DI). For the second study, rats were further subdivided. Some Cap-treated rats continued on this treatment, and the other half were now given DI to determine whether there would be residual effects of Cap treatment. A subgroup of rats who had received DI was then given Arg, whereas the rest remained on DI. In the first study, Cap-treated rats exhibited decreases in systolic and diastolic blood pressures, frequency of breathing, and minute ventilation, but ventilatory control was maintained. In contrast, blood pressures and relative ventilation to metabolism were higher in the DI-treated group. Removal of Cap increased blood pressure and decreased tidal volume while these rats maintained frequency. Although Arg-treated rats did not exhibit a decrease of blood pressure, ventilation was maintained in this group by preserving tidal volume. Thus Cap and Arg affected ventilation through different mechanisms independent of blood pressure.spontaneously hypertensive heart failure rat; hypertension; metabolic syndrome X; ventilatory equivalent; frequency OBESITY, DIABETES, AND HYPERTENSION are major risk factors for cardiopulmonary and renal disease (1,7,9,18,41). The concurrence of these risk factors is also known as the metabolic syndrome X (8, 49). In addition to metabolic and cardiovascular complications, individuals with metabolic syndrome X can also present with hypoventilation during sleep and obstructive sleep apnea (8, 47).Hypertension and congestive heart failure originate from the activation of multiple neuroendocrine systems, including the renin-angiotensin (Ang), endothelin, and atrial natriuretic peptide systems (13, 23-25, 41, 51). One in four adults develops hypertension and is at increased risk of stroke, coronary disease, congestive heart failure, and end-stage renal disease (2). Ang-converting enzyme (ACE) inhibitors are regarded as the first line of hypertensive therapy in diabetic patients due to their protective effects on the cardiovascular and renal systems (23,27,45). Ideally, treatment of hypertension would normalize blood pressure early in the disease, thus decreasing the incidence of cardiovascular-associated morbidity and mortality. Another agent that has been shown to decrease blood pressure is L-arginine (Arg) (50), a substrate ...

show abstract

Section: Discussionsupporting

confidence: 48%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Effects of long-term captopril andl-arginine treatment on ventilation and blood pressure in obese male SHHF rats

Schlenker

Kost

Likness

2004

Journal of Applied Physiology

View full text Add to dashboard Cite

show abstract

“…A confounding factor in this type of experiments is the increase in blood pressure caused by L-NAME administration (Forster et al, 2001). High blood pressure is a stressor that may affect prolactin secretion as was previously shown by using other experimental approaches (Van den Berghe, 2001).…”

Section: Discussionmentioning

confidence: 89%

Effect of nitric oxide on prolactin secretion and hypothalamic biogenic amine contents

et al. 2004

View full text Add to dashboard Cite

“…This action of l-NAME has been previously noted in Sprague-Dawley rats whether administered orally, injected into a cerebral ventricle, or, as in this experiment, infused intravenously [22,23]. However, an increase in blood pressure has not been shown to directly affect neutrophil sequestration in the lungs [24].…”

Section: Discussionmentioning

confidence: 51%

l-NAME–induced neutrophil accumulation in rat lung is not entirely because of interactions with L- and P-selectins or CD18

Román

McGahren

2006

Journal of Pediatric Surgery

View full text Add to dashboard Cite

The Effect of Nitric Oxide Inhibition on Blood Pressure Depends on Rat Strain

Cited by 11 publications

References 30 publications

Effects of long-term captopril andl-arginine treatment on ventilation and blood pressure in obese male SHHF rats

Effects of long-term captopril andl-arginine treatment on ventilation and blood pressure in obese male SHHF rats

Effect of nitric oxide on prolactin secretion and hypothalamic biogenic amine contents

l-NAME–induced neutrophil accumulation in rat lung is not entirely because of interactions with L- and P-selectins or CD18

Contact Info

Product

Resources

About